{
  "openalex_id": "W4411291738",
  "doi": "https://doi.org/10.2337/db25-1209-p",
  "title": "1209-P: Barriers to Home A1C Collection Completion among Emerging Adults with Type 1 Diabetes",
  "abstract": "Introduction and Objective: For measuring A1C, clinic-based A1C analyzers are the gold standard, yet home A1C collection kits offer an alternative for virtual care and research studies. ARDL (University of Minnesota Advanced Research and Diagnostic Laboratory) collection kits are an accurate option for at-home capillary A1C collection. The purpose of this analysis is to identify challenges associated with using home A1C collection kits. Home A1C collection kits were used at baseline visits for a virtual study among emerging adults (ages 18-30) with T1D across diverse geographic locations. Methods: ARDL A1C collection kits were mailed to 95 participants at baseline. REDCap automated alerts and email/text check-ins on collection completion were sent to participants and shipment tracking was documented. An inductive thematic analysis of 102 participant interactions (phone/email) in REDCap was conducted to identify challenges. Interactions were filtered by the keywords \"A1C\" and \"A1C Kit\", then categorized by theme and frequency. Results: Of the 102 interactions documented, challenges were unique to 37 of 95 participants (39%). Common interactions were related to A1C collection completion (n=23, 23% of interactions) and documentation completion (n=11, 11% of interactions). Four main themes of challenges emerged: mailing/tracking, completion/documentation, instructional support, and collection results/storage. A1C collection and storage issues were rare. Conclusion: The analysis highlights the need for clear instructions and notification systems for collection reminders and completion. To improve the process, we will add automated alerts with expected A1C kit completion deadlines, implement personalized follow-ups via phone and email, offer Zoom training, and deliver test kits earlier. These improvements aim to enhance kit usage and result collection in future cohorts, particularly among diverse, public-insured, hard-to-reach populations. Disclosure A.K. Kanchibhatla: None. J. Rieke: None. C.S. Shannon: None. M. Roche: None. K. Bass: None. B. Hatipoglu: Research Support; Tandem Diabetes Care, Inc, Diasome Pharmaceuticals. J.E. Blanchette: Speaker's Bureau; Insulet Corporation. Research Support; Leona M. and Harry B. Helmsley Charitable Trust. Advisory Panel; Eli Lilly and Company, Cardinal Health/Edgepark. Consultant; embecta. Research Support; National Institute of Diabetes and Digestive and Kidney Diseases. Board Member; Juvenile Diabetes Research Foundation (JDRF). Funding The Leona M. and Harry B. Helmsley Charitable Trust (G-2305- 05992)",
  "authors": [
    {
      "display_name": "Anuhya Kanchibhatla",
      "id": "A5093540035",
      "orcid": "https://orcid.org/0009-0002-7181-9809",
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "ANUHYA K. KANCHIBHATLA"
    },
    {
      "display_name": "Jorden Rieke",
      "id": "A5092695892",
      "orcid": "https://orcid.org/0000-0001-6813-9699",
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "JORDEN RIEKE"
    },
    {
      "display_name": "CHANTEL S. SHANNON",
      "id": "A5109733175",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "CHANTEL S. SHANNON"
    },
    {
      "display_name": "MARY JANE ROCHE",
      "id": "A5013745061",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "MARY JANE ROCHE"
    },
    {
      "display_name": "Karma Bass",
      "id": "A5044751452",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "KIMBERLY BASS"
    },
    {
      "display_name": "BETUL HATIPOGLU",
      "id": "A5019093859",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "BETUL HATIPOGLU"
    },
    {
      "display_name": "Julia E. Blanchette",
      "id": "A5003218012",
      "orcid": "https://orcid.org/0000-0002-6714-4792",
      "institutions": [
        {
          "id": "I4210166942",
          "display_name": "Think A Move (United States)",
          "country_code": "US",
          "type": "company"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "JULIA E. BLANCHETTE"
    }
  ],
  "publication_year": 2025,
  "publication_date": "2025-06-13",
  "type": "article",
  "cited_by_count": 0,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S129060628",
    "display_name": "Diabetes",
    "issn_l": "0012-1797",
    "issn": [
      "0012-1797",
      "1939-327X"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320274"
  },
  "volume": "74",
  "issue": "Supplement_1",
  "first_page": null,
  "last_page": null,
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2777180221",
      "display_name": "Type 2 diabetes",
      "level": 3,
      "score": 0.6500435
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.56141627
    },
    {
      "id": "C555293320",
      "display_name": "Diabetes mellitus",
      "level": 2,
      "score": 0.48329213
    },
    {
      "id": "C74909509",
      "display_name": "Gerontology",
      "level": 1,
      "score": 0.37488723
    },
    {
      "id": "C134018914",
      "display_name": "Endocrinology",
      "level": 1,
      "score": 0.18960592
    }
  ],
  "topics": [
    {
      "id": "T10560",
      "display_name": "Diabetes Management and Research",
      "score": 0.9934
    },
    {
      "id": "T10401",
      "display_name": "Diabetes Treatment and Management",
      "score": 0.9765
    },
    {
      "id": "T11171",
      "display_name": "Diabetes and associated disorders",
      "score": 0.974
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.2337/db25-1209-p",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T15:43:50.722029",
  "source_database": "OpenAlex"
}